BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9100682)

  • 1. Prognostic factors of node-negative gastric carcinoma: univariate and multivariate analyses.
    Adachi Y; Mori M; Maehara Y; Kitano S; Sugimachi K
    J Am Coll Surg; 1997 Apr; 184(4):373-7. PubMed ID: 9100682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is tumor size a prognostic indicator for gastric carcinoma?
    Yokota T; Ishiyama S; Saito T; Teshima S; Yamada Y; Iwamoto K; Takahashi M; Murata K; Yamauchi H
    Anticancer Res; 2002; 22(6B):3673-7. PubMed ID: 12552975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival predictors in patients with node-negative gastric carcinoma.
    Lee CC; Wu CW; Lo SS; Chen JH; Li AF; Hsieh MC; Shen KH; Lui WY
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1014-8. PubMed ID: 17608847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significant prognostic factors in patients with early gastric cancer.
    Yokota T; Kunii Y; Teshima S; Yamada Y; Saito T; Takahashi M; Kikuchi S; Yamauchi H
    Int Surg; 2000; 85(4):286-90. PubMed ID: 11589593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathology and prognosis of gastric carcinoma: well versus poorly differentiated type.
    Adachi Y; Yasuda K; Inomata M; Sato K; Shiraishi N; Kitano S
    Cancer; 2000 Oct; 89(7):1418-24. PubMed ID: 11013353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors of advanced gastric carcinoma without serosal invasion (pT2 gastric carcinoma).
    Isozaki H; Fujii K; Nomura E; Mabuchi H; Nishiguchi K; Hara H; Tanigawa N
    Hepatogastroenterology; 1999; 46(28):2669-72. PubMed ID: 10522062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant prognostic factors in patients with node-negative gastric cancer.
    Yokota T; Kunii Y; Teshima S; Yamada Y; Saito T; Takahashi M; Kikuchi S; Yamauchi H
    Int Surg; 1999; 84(4):331-6. PubMed ID: 10667813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of para-aortic lymph node dissection in advanced gastric cancer.
    Kunisaki C; Shimada H; Yamaoka H; Wakasugi J; Takahashi M; Akiyama H; Nomura M; Moriwaki Y
    Hepatogastroenterology; 1999; 46(28):2635-42. PubMed ID: 10522056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of perineural invasion in patients with gastric cancer who underwent curative resection.
    Bilici A; Seker M; Ustaalioglu BB; Kefeli U; Yildirim E; Yavuzer D; Aydin FM; Salepci T; Oncel M; Gumus M
    Ann Surg Oncol; 2010 Aug; 17(8):2037-44. PubMed ID: 20333555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic prognostic factors in patients with Borrmann type 4 gastric cancer: univariate and multivariate analyses.
    Yokota T; Kunii Y; Saito T; Teshima S; Narushima Y; Yamada Y; Iwamoto K; Kagami M; Takahashi M; Kikuchi S; Yamauchi H
    Ups J Med Sci; 2000; 105(3):227-34. PubMed ID: 11261608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The significance of perineural invasion as a prognostic factor in patients with gastric carcinoma.
    Duraker N; Sişman S; Can G
    Surg Today; 2003; 33(2):95-100. PubMed ID: 12616368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of lymphatic invasion in patients with node-negative gastric cancer.
    Ichikawa D; Kubota T; Kikuchi S; Fujiwara H; Konishi H; Tsujiura M; Ikoma H; Nakanishi M; Okamoto K; Sakakura C; Ochiai T; Kokuba Y; Otsuji E
    J Surg Oncol; 2009 Aug; 100(2):111-4. PubMed ID: 19475584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic and clinical evaluation of patients with T2 gastric cancer.
    Komatsu S; Ichikawa D; Kurioka H; Kan K; Shioaki Y; Ueshima Y; Hamashima T; Lee CJ; Ikeda E; Ueda Y; Otsuji E; Oka T; Yamagishi H
    Hepatogastroenterology; 2005; 52(63):965-8. PubMed ID: 15966242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multivariate prognostic study on large gastric cancer.
    Shiraishi N; Sato K; Yasuda K; Inomata M; Kitano S
    J Surg Oncol; 2007 Jul; 96(1):14-8. PubMed ID: 17582596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for lymph node metastasis from intramucosal gastric carcinoma.
    Yamao T; Shirao K; Ono H; Kondo H; Saito D; Yamaguchi H; Sasako M; Sano T; Ochiai A; Yoshida S
    Cancer; 1996 Feb; 77(4):602-6. PubMed ID: 8616749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of level and number of lymph node metastases in patients with gastric cancer.
    Saito H; Fukumoto Y; Osaki T; Fukuda K; Tatebe S; Tsujitani S; Ikeguchi M
    Ann Surg Oncol; 2007 May; 14(5):1688-93. PubMed ID: 17245613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic effects of transabdominal radical total gastrectomy on cardiac cancer: analysis of 56 cases].
    Wu T; Wan YL; Rong L; Pan YS; Wang X; Liu YC
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1474-7. PubMed ID: 17785085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
    Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
    Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. General and specific prognostic factors of early gastric carcinoma treated with curative surgery.
    Isozaki H; Tanaka N; Okajima K
    Hepatogastroenterology; 1999; 46(27):1800-8. PubMed ID: 10430349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathology and prognosis of mucinous gastric carcinoma.
    Hidaka S; Tanaka K; Takeshita H; Sumida Y; Fukuoka H; Abo T; Yano H; Nanashima A; Sawai T; Yasutake T; Nagayasu T
    Hepatogastroenterology; 2008; 55(82-83):791-4. PubMed ID: 18613456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.